CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To screen the potential DUBs involved in the pathogenesis of CML, we compared the expression of DUBs in primary CML cells (chronic phase, n = 5) and normal bone marrow (BM) CD34+ cells (n = 3).